Drug delivery to the posterior segment of the eye for pharmacologic therapy
Shalin Shah(Maulana Azad Medical College), James M. Hill(University of Oxford), Partha S. Bhattacharjee(National Oceanic and Atmospheric Administration), Lori Vidal Denham(Tulane University), J. Elison(Louisiana State University), Tashfin S. Huq(Xavier University of Louisiana), Christian Clément(Ophthalmology Associates (United States))
Cited by 99
Related Papers
Current and Emerging Developments in Subseasonal to Decadal Prediction
|Bulletin of the American Meteorological Society|2020|311
Current state of the global operational aerosol multi‐model ensemble: An update from the International Cooperative for Aerosol Prediction (ICAP)
|Quarterly Journal of the Royal Meteorological Society|2019|153
Ocular HSV-1 Latency, Reactivation and Recurrent Disease
|Seminars in Ophthalmology|2008|142
Ocular Herpes Simplex Virus: How are Latency, Reactivation, Recurrent Disease and Therapy Interrelated?
|Future Microbiology|2011|116
Rabbit and Mouse Models of HSV-1 Latency, Reactivation, and Recurrent Eye Diseases
|BioMed Research International|2012|91